医学
肺癌
放射外科
肿瘤科
癌症
内科学
进行性疾病
放射治疗
疾病
作者
Jacob Langston,Tejas Patil,D. Ross Camidge,Paul A. Bunn,Erin L. Schenk,Jose M. Pacheco,James Jurica,Timothy V. Waxweiler,Brian D. Kavanagh,Chad G. Rusthoven
出处
期刊:Lung Cancer
[Elsevier]
日期:2023-04-01
卷期号:178: 103-107
被引量:6
标识
DOI:10.1016/j.lungcan.2023.02.006
摘要
For extensive brain metastases (BrM) presentations arising from oncogene-addicted lung cancer, tyrosine kinase inhibitors (TKIs) with high response rates in the central nervous system (CNS) could potentially downstage the CNS disease burden, allowing for the avoidance of upfront whole-brain radiotherapy (WBRT) and the conversion of some patients into candidates for focal stereotactic radiosurgery (SRS).
科研通智能强力驱动
Strongly Powered by AbleSci AI